Clinical Trials Open to People Under 18
(127 trials open to new patients)

• Acute Lymphoblastic Leukemia (16 open to new patients)
• Acute Myeloid Leukemia (6 open to new patients)
• Adrenocortical Carcinoma (1 open to new patients)
• Anaplastic Ganglioglioma (1 open to new patients)
• Anaplastic Pleomorphic Xanthoastrocytoma (1 open to new patients)
• Anemia (2 open to new patients)
• Astrocytoma (10 open to new patients)
• Atrial Septal Defect (1 open to new patients)
• Atypical Teratoid Rhabdoid Tumor (1 open to new patients)
• Autism (1 open to new patients)
• Autoimmune Disease (1 open to new patients)
• Brain Tumor (8 open to new patients)
• BRCA 1 Gene Mutation (1 open to new patients)
• BRCA 2 Gene Mutation (1 open to new patients)
• Breast Cancer (1 open to new patients)
• Cancer, General (5 open to new patients)
• Carcinoma in Situ (1 open to new patients)
• Cardiotoxicity (1 open to new patients)
• Central Nervous System Embryonal Tumor (1 open to new patients)
• Central Nervous System Neoplasm (7 open to new patients)
• Chordoma (1 open to new patients)
• Choriocarcinoma (2 open to new patients)
• CNS Tumor (1 open to new patients)
• Colon Cancer (1 open to new patients)
• Colorectal Cancer (1 open to new patients)
• Congenital Mesoblastic Nephroma (1 open to new patients)
• Desmoid-Type Fibromatosis (1 open to new patients)
• Disease (1 open to new patients)
• Disorders of the Immune System (1 open to new patients)
• Down Syndrome (2 open to new patients)
• Dysplasia (1 open to new patients)
• Endometrial Cancer (1 open to new patients)
• Ependymal Tumor (1 open to new patients)
• Ependymoma (11 open to new patients)
• Epilepsy (1 open to new patients)
• Ewing Sarcoma (14 open to new patients)
• Extragonadal Embryonal Carcinoma (1 open to new patients)
• EZH2 Gene Mutation (1 open to new patients)
• Fibrolamellar Carcinoma (1 open to new patients)
• Ganglioneuroblastoma (3 open to new patients)
• Germ Cell Tumor (13 open to new patients)
• Glioblastoma (8 open to new patients)
• Glioma (27 open to new patients)
• Gliosis (1 open to new patients)
• Graft Versus Host Disease (1 open to new patients)
• Head and Neck Cancer (1 open to new patients)
• Head and Neck Squamous Cell Carcinoma (1 open to new patients)
• Heart Failure (2 open to new patients)
• Hematologic Malignancies (1 open to new patients)
• Hematopoietic Cell Transplantation (1 open to new patients)
• Hemimegalencephaly (1 open to new patients)
• Hemispheric (1 open to new patients)
• Hepatoblastoma (13 open to new patients)
• Hepatocellular Carcinoma (2 open to new patients)
• Histiocytic and Dendritic Cell Neoplasm (1 open to new patients)
• Histiocytic Disorders (1 open to new patients)
• HLA-A*0201 Positive Cells Present (1 open to new patients)
• Hodgkin's Lymphoma (19 open to new patients)
• IDH1 Gene Mutation (1 open to new patients)
• IDH2 Gene Mutation (1 open to new patients)
• Immunotherapy (3 open to new patients)
• Infantile Fibrosarcoma (1 open to new patients)
• Inflammatory Bowel Disease (1 open to new patients)
• Inherited Abnormalities of Platelets (1 open to new patients)
• Inherited Disorders of Metabolism (1 open to new patients)
• INI1-negative Tumors (1 open to new patients)
• Intracranial Neoplasm (1 open to new patients)
• Juvenile Xanthogranuloma (1 open to new patients)
• Kidney Cancer (2 open to new patients)
• Langerhans Cell Histiocytosis (13 open to new patients)
• Leukemia (24 open to new patients)
• Liposarcoma (1 open to new patients)
• Liver Cancer (2 open to new patients)
• Locally Advanced Chordoma (1 open to new patients)
• Loss of Heterozygosity (1 open to new patients)
• Lung Cancer (6 open to new patients)
• Lung Non-Small Cell Carcinoma (2 open to new patients)
• Lung Non-Small Cell Squamous Carcinoma (1 open to new patients)
• Lung Non-Squamous Non-Small Cell Carcinoma (1 open to new patients)
• Lymphoma (29 open to new patients)
• Lymphoproliferative Disorder (1 open to new patients)
• Macrocephaly (1 open to new patients)
• Malignant Germ Cell Neoplasm (1 open to new patients)
• Malignant Neoplasm (9 open to new patients)
• Malignant Rhabdoid Tumor (1 open to new patients)
• Malignant Solid Neoplasm (14 open to new patients)
• MAPK1 Gene Mutation (1 open to new patients)
• Medulloblastoma (14 open to new patients)
• Melanoma (3 open to new patients)
• Metastatic Chordoma (1 open to new patients)
• Movement Disorders (1 open to new patients)
• Multiple Myeloma (1 open to new patients)
• Myelodysplastic Syndrome (3 open to new patients)
• Myeloproliferative Neoplasms (2 open to new patients)
• Neoplasms (6 open to new patients)
• Neoplasms by Site (1 open to new patients)
• Neuroblastoma (24 open to new patients)
• Neuroectodermal Tumors (1 open to new patients)
• Neurofibromatosis (2 open to new patients)
• Non Hodgkin Lymphoma (16 open to new patients)
• Non-Small Cell Lung Cancer (5 open to new patients)
• NY-ESO-1 Positive (1 open to new patients)
• Osteosarcoma (13 open to new patients)
• Ovarian Embryonal Carcinoma (1 open to new patients)
• Ovarian Tumor (2 open to new patients)
• Pediatric Cancer (2 open to new patients)
• Pediatric Central Nervous System Tumor (1 open to new patients)
• Peripheral Primitive Neuroectodermal Tumor (7 open to new patients)
• Polymicrogyria (1 open to new patients)
• Primary Central Nervous System Neoplasm (5 open to new patients)
• Primary CNS Tumors (1 open to new patients)
• Primary Malignant Central Nervous System Neoplasm (2 open to new patients)
• PTEN (1 open to new patients)
• PTEN Hamartoma Tumor Syndrome (1 open to new patients)
• Rasmussen Encephalitis (1 open to new patients)
• Refractory Central Nervous System Neoplasm (1 open to new patients)
• Refractory Central Nervous System Tumor (1 open to new patients)
• Refractory Hepatoblastoma (7 open to new patients)
• Refractory Malignant Solid Neoplasm (13 open to new patients)
• Refractory Osteosarcoma (9 open to new patients)
• Relapsed Central Nervous System Tumor (1 open to new patients)
• Renal Cell Carcinoma (2 open to new patients)
• Rhabdoid Tumor (12 open to new patients)
• Rhabdomyosarcoma (15 open to new patients)
• Sarcoma (18 open to new patients)
• Seizures (1 open to new patients)
• Seminoma (1 open to new patients)
• Sickle Cell Anemia (1 open to new patients)
• Skin Cancer/Melanoma (3 open to new patients)
• SMARCA4 Gene Inactivation (1 open to new patients)
• SMARCB1 Gene Inactivation (1 open to new patients)
• Soft Tissue Sarcoma (13 open to new patients)
• Solid Neoplasm (3 open to new patients)
• Solid Tumor (27 open to new patients)
• Spinal Column Tumor (1 open to new patients)
• Squamous Cell Carcinoma (1 open to new patients)
• Stroke (1 open to new patients)
• Stromal Neoplasm (1 open to new patients)
• Sturge-Weber Syndrome (1 open to new patients)
• Synovial Sarcoma (1 open to new patients)
• T Cell Lymphoma (2 open to new patients)
• Teratoma (3 open to new patients)
• Testicular Cancer (1 open to new patients)
• Testicular Tumor (1 open to new patients)
• Thyroid Cancer (2 open to new patients)
• Thyroid Gland Medullary Carcinoma (1 open to new patients)
• Transitional Cell Carcinoma (1 open to new patients)
• Tuberous Sclerosis (1 open to new patients)
• Unresectable Chordoma (1 open to new patients)
• Uterine Cancer (1 open to new patients)
• Wilms Tumor (12 open to new patients)